The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
ABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5 mL bivalent vaccine powder for injection vial + diluent syringe (406624)
ARTG Name
ABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5 mL bivalent vaccine powder for injection vial + diluent syringe
Product name
ABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5mL bivalent vaccine powder for injection vial and diluent syringe
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
recombinant respiratory syncytial virus pre-fusion F protein
water for injections
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information